Live bacterium B. thetaiotaomicron
Key facts
Active substance |
Live bacterium B. thetaiotaomicron
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/166/2009
|
PIP number |
Live bacterium B. thetaiotaomicron
|
Pharmaceutical form(s) |
Live Bacteria in an Enteric Coated Capsule
|
Condition(s) / indication(s) |
Treatment of Crohn's disease
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
4D Pharma Research Ltd
|
Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|